Cepheid announced it has received clearance from the FDA to market Xpert SA Nasal Complete, a molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization.
Read More
Catalyst Development CorpWaters Corp
Read MoreBiomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read MoreResearchers believe that genetics and traditional screening methods could play a role in predicting the risk of prostate cancer in younger men.
Read MoreClinical and Laboratory Standards Institute (CLSI) has recently published Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests; Approved Guideline — Fourth Edition (H18-A4).
Read More